Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated After Starting Hu14.18-IL2 Predicts Outcome
Biomarkers (2)
- PERCENTAGE _CD3-CELLS - Retrospective pathologic assessment of percentage (%) of tumor infiltrating CD3+ cells (phv00430314.v1.p1)
- PERCENTAGE_CD8A-CELLS - Retrospective pathologic assessment of percentage (%) of tumor infiltrating CD8a+ cells (phv00430316.v1.p1)
Demographics (2)
- AGE - Subject's age at surgerical resection (phv00430309.v1.p1)
- SEX - Self-reported sex (phv00430307.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00430308.v1.p1)
Other (26)
- ANALYTE_TYPE - Analyte Type (phv00430326.v1.p1)
- ARM - Treatment group (phv00430310.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00430325.v1.p1)
- CD8A_PATTERN - Pathologic assessment of immunogenicity of tumor with three categories (Hot, Cold, Excluded) (phv00430317.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00430303.v1.p1)
- CYCLES_HU14.18-IL2 - Number of completed cycles of immunocytokine hu14.18-IL2 (phv00430312.v1.p1)
- DEATH - Patient died due to disease (phv00430318.v1.p1)
- GENOTYPING_CENTER - Name of center which did genotyping (phv00430331.v1.p1)
- GEO_Sample_ID - GEO sample accession (phv00430323.v1.p1)
- HISTOLOGICAL_TYPE - Tissue histology (phv00430328.v1.p1)
- IS_TUMOR - Tumor status (phv00430327.v1.p1)
- OVERALL_SURVIVAL - Duration between the enrollment on the study and death (phv00430319.v1.p1)
- PERCENTAGE_TILS - Retrospective pathologic assessment of percentage (%) of tumor infiltrating lymphocytes (TILs) (phv00430315.v1.p1)
- PRE-SURGERY TREATMENT - Treatment given before sugery (phv00430330.v1.p1)
- PRE-SURGERY_TREATMENT - Pre-surgery immunotherapy treatment of Hu14.18-IL2 (phv00430311.v1.p1)
- RECURRENCE - Patient had disease recurrence (phv00430320.v1.p1)
- RECURRENCE-FREE_SURVIVAL - Duration between the enrollment on the study and recurrence (phv00430321.v1.p1)
- SAMPLE_ID - Sample identification (phv00430324.v1.p1)
- SAMPLE_ID - Sample ID (phv00430305.v1.p1)
- SAMPLE_ID - Sample ID (phv00430322.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430332.v1.p1)
- SUBJECT_ID - Subject ID (phv00430306.v1.p1)
- SUBJECT_ID - Patient ID (phv00430302.v1.p1)
- SUBJECT_ID - Patient ID (phv00430304.v1.p1)
- Time_Resection - IC - Time prior to surgery at the initiation of hu14.18-IL2 treatment (phv00430313.v1.p1)
- TUMOR_PREP - Tumor preparation (phv00430329.v1.p1)